Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2023.
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies, has received approval from Australia's medicines and medical devices regulator, Therapeutic Goods Administration (TGA) for its facility in Khatraj, Gujarat.
Ahmedabad-based drug maker Lincoln Pharmaceuticals Ltd has acquired a facility in Mehsana that makes antibiotics used in the treatment of pneumonia and bronchitis, among other ailments.
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies, is planning to launch cephalosporin products soon.
Drug firm Lincoln Pharmaceuticals NSE -2.56 % on Thursday said the National Company Law Tribunal, Ahmedabad Bench, has approved the scheme of amalgamation of Lincoln Parenteral Ltd and the company. Amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd is expected to bring lots of synergies in terms of operations efficiency, enhance competitive strength, cost-effectiveness and productivity for the combined entity, Lincoln Pharma ..
National Company Law Tribunal, Ahmedabad Bench, (NCLT) has approved the scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. Amalgamation is expected to bring lot of synergies in terms of operations efficiency, enhance competitive strength, cost-effectiveness and productivity for the combined entity.
Shares of pharmaceutical companies were on a roll at the bourses on Friday, with the S&P BSE Healthcare index surging nearly 3 per cent to hit its record high on the back of positive news flow.
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has received the European Union (EU) GMP certification from Germany FDA for its manufacturing facility located at Khatraj in Gujarat. The certification will allow the company to market its products in all the 27 member countries of EU and also give access to the European Economic Area (EEA) countries. The company looks to enter the EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.
Lincoln Pharmaceuticals has received the European Union (EU) GMP certification from Germany FDA for its manufacturing facility located at Khatraj in Gujarat. The certification will allow the company to market its products in all the 27 member countries of EU and also give access to the European Economic Area (EEA) countries. The company looks to enter the EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.
New Delhi: Lincoln Pharmaceuticals on Monday said it has received approval from the Gujarat Food and Drug Control Administration to manufacture hydroxychloroquine (HCQ) among other critical drugs to treat COVID-19, at its Khatraj facility in Ahmedabad. The company has received approval from the state regulator to manufacture varied dosages of HCQ tablets and HCQ sulfate tablets among others at Khatraj plant, Lincoln Pharma said in a statement.